Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.88
+0.50 (3.25%)
At close: May 22, 2026, 4:00 PM EDT
15.60
-0.28 (-1.76%)
After-hours: May 22, 2026, 7:35 PM EDT
Rallybio Revenue
Rallybio had revenue of $212.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $858.00K, up 1.18% year-over-year. In the year 2025, Rallybio had annual revenue of $858.00K with 34.91% growth.
Revenue (ttm)
$858.00K
Revenue Growth
+1.18%
P/S Ratio
97.90
Revenue / Employee
$61,286
Employees
14
Market Cap
84.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 858.00K | 222.00K | 34.91% |
| Dec 31, 2024 | 636.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atara Biotherapeutics | 23.14M |
| MindWalk Holdings | 20.70M |
| Alterity Therapeutics | 4.43M |
| Seres Therapeutics | 1.15M |
| eXoZymes | -700.00 |
RLYB News
- 2 months ago - Rallybio Annual report: Q4 2025 - Filings
- 2 months ago - Rallybio, Candid Therapeutics announce merger agreement - TheFly
- 2 months ago - Rallybio Transcript: M&A announcement - Transcripts
- 2 months ago - Rallybio Press release: M&A announcement - Filings
- 2 months ago - Rallybio Corporation and Candid Therapeutics Announce Merger Agreement - Business Wire
- 3 months ago - Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement - Business Wire
- 3 months ago - Rallybio Corp trading halted, news pending - TheFly
- 3 months ago - Rallybio announces reverse 1-for-8 stock split - TheFly